Zenith Flex G32182Recalls & reported problems
Cook Incorporated · Zenith Flex, AAA Main Body Extension · Class 3 · Implant
All models of Zenith Flex (54)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10827002321820), received between Jun 12, 2018 and Jul 16, 2019 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Failure to Advance” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Failure to Advance1
- Fluid/Blood Leak1
- Material Frayed1
Patient problems
- No Code Available1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 16, 2019Fluid/Blood Leak; Fluid/Blood Leak
ON (B)(6) 2013 THE PATIENT WAS TREATED FOR AN ASYMPTOMATIC ANEURYSM WITH A MAXIMUM DIAMETER OF 5.3CM. ACCESS WAS OBTAINED THROUGH A CUT-DOWN, WITH AN ABDOMINAL AORTIC STENT GRAFT, MAIN BODY EXTENSION AND BILATERAL LEGS BEING PLACED. THE NECK QUALITY AND SHAPE CLASSIFICATION WAS PARALLEL WITH PARTIAL OCCLUSION FROM PLAQUE/THROMBUS. ADDITIONAL INTERVENTIONS INCLUDED PLACEMENT OF A COVERED STENT IN THE RIGHT ILIAC ARTERY DUE TO A TYPE I ENDOLEAK. THERE WAS NO DIFFICULTY DEPLOYING THE DEVICES, AND WERE FOUND TO BE INTACT AND PATENT WITH NO KINKS OR ENDOLEAKS AT THE END OF THE PROCEDURE. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2019. POST-PROCEDURE ECHO-DOPPLER IMAGING PERFORMED ON (B)(6) 2019 FOUND THE DEVICES TO BE INTACT AND PATENT, WITH NO EVIDENCE OF KINKS, ENDOLEAKS OR MIGRATION. FOLLOW UP IMAGING VIA ECHO-DOPPLER ON (B)(6) 2014 AND CT SCAN ON (B)(6) 2015 FOUND THE DEVICES TO BE INTACT AND PATENT, WITH NO EVIDENCE OF STENOSIS, MIGRATION OR KINKS. A TYPE II ENDOLEAK WAS NOTED ON BOTH OCCURRENCES. THIRD AND FOURTH YEAR FOLLOW UP IMAGING WAS NOT COMPLETED. ON (B)(6) 2018, THE PATIENT UNDERWENT A SECONDARY INTERVENTION TO TREAT TYPE I AND TYPE III ENDOLEAKS, WHICH INCLUD
Patient problems: No Code Available
MAUDE report 8793828 ↗MalfunctionJun 12, 2018Material Frayed; Failure to Advance
IT WAS REPORTED THAT THE PHYSICIAN INTENDED TO PLACE A ZENITH AAA ENDOVASCULAR GRAFT AAA ANCILLARY COMPONENT MAIN BODY EXTENSION TO PREVENT FURTHER ENLARGEMENT OF THE ANEURYSM. THE DEVICE WAS ADVANCED FROM THE RIGHT FEMORAL ARTERY, BUT IT BECAME CAUGHT ON THE DISTAL SIDE OF THE PREVIOUSLY PLACED LEG GRAFT AND WOULD NOT ADVANCE. THE WIRE WAS THEN REPLACED WITH A STIFFER ONE, BUT THE DELIVERY SYSTEM STILL WOULD NOT ADVANCE, SO IT WAS REMOVED FROM THE PATIENT. THE USER THEN FOUND THAT THE TIP OF THE DELIVERY SHEATH WAS FRAYED. THE TIP WAS MANUALLY AMENDED AND REINSERTED FROM THE LEFT SIDE, BUT IT STILL FAILED TO ADVANCE. THIS PART OF THE PROCEDURE WAS ABANDONED, BUT THE REST OF THE PROCEDURE WAS COMPLETED WITH A COIL EMBOLIZATION OF THE LEFT INTERNAL ILIAC ARTERY AND PLACEMENT OF ANOTHER STENT GRAFT IN THE EXTERNAL ILIAC ARTERY. THERE WERE NO INJURIES OR ADDITIONAL PROCEDURES REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7593639 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page